Evidence map›Paper›PMID 28803391›Full record

ArticleFamilial cancer2018

Mutational analysis of the RB1 gene and the inheritance patterns of retinoblastoma in Jordan.

Yacoub A Yousef, Abdelghani Tbakhi, Maysa Al-Hussaini, Ibrahim AlNawaiseh, Ala Saab, Amal Afifi, Maysa Naji, Mona Mohammad, Rasha Deebajah, Imad Jaradat and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Familial cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Mutational analysis of theFrontiers in medicine · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yacoub A YousefDepartment of Surgery/Ophthalmology, King Hussein Cancer Center, Queen Rania Al-Abdullah Street, P.O Box 1269, Amman, 11941, Jordan.
Abdelghani TbakhiDepartment of Cell Therapy and Applied Genomics, King Hussein Cancer Center, Amman, Jordan.
Maysa Al-HussainiDepartment of Pathology, King Hussein Cancer Center, Amman, Jordan.
Ibrahim AlNawaisehDepartment of Surgery/Ophthalmology, King Hussein Cancer Center, Queen Rania Al-Abdullah Street, P.O Box 1269, Amman, 11941, Jordan.
Ala SaabDepartment of Surgery/Ophthalmology, King Hussein Cancer Center, Queen Rania Al-Abdullah Street, P.O Box 1269, Amman, 11941, Jordan.
Amal AfifiDepartment of Cell Therapy and Applied Genomics, King Hussein Cancer Center, Amman, Jordan.
Maysa NajiDepartment of Pediatric Oncology, King Hussein Cancer Center, Amman, Jordan.
Mona MohammadDepartment of Surgery/Ophthalmology, King Hussein Cancer Center, Queen Rania Al-Abdullah Street, P.O Box 1269, Amman, 11941, Jordan.
Rasha DeebajahDepartment of Pediatric Oncology, King Hussein Cancer Center, Amman, Jordan.
Imad JaradatDepartment of Radiotherapy, King Hussein Cancer Center, Amman, Jordan.
Iyad SultanDepartment of Pediatric Oncology, King Hussein Cancer Center, Amman, Jordan.
Mustafa MehyarDepartment of Surgery/Ophthalmology, King Hussein Cancer Center, Queen Rania Al-Abdullah Street, P.O Box 1269, Amman, 11941, Jordan. mustafamehyar@yahoo.com.
King Hussein Cancer Center · JO

Funding

King Hussein Cancer Center 13KHCC25
6 · The paper itself

Abstract

Retinoblastoma (RB) is a childhood cancer developing in the retina due to RB1 pathologic variant. Herein we are evaluating the oncogenic mutations in the RB1 gene and the inheritance patterns of RB in the Jordanian patients. In this prospective study, the peripheral blood of 50 retinoblastoma patients was collected, genomic DNA was extracted, mutations were identified using Quantitative multiplex PCR (QM-PCR), Allele-specific PCR, Next Generation Sequencing analysis, and Sanger sequencing. In this cohort of 50 patients, 20(40%) patients had unilateral RB and 30(60%) were males. Overall, 36(72%) patients had germline disease, 17(47%) of whom had the same RB1 pathologic variant detected in one of the parents (inherited disease). In the bilateral group, all (100%) patients had germline disease; 13(43%) of them had inherited mutation. In the unilateral group, 6(30%) had germline disease, 4(20%) of them had inherited mutation. Nonsense mutation generating a stop codon and producing a truncated non-functional protein was the most frequent detected type of mutations (n = 15/36, 42%). Only one (2%) of the patients had mosaic mutation, and of the 17 inherited cases, 16(94%) had an unaffected carrier parent. In conclusion, in addition to all bilateral RB patients in our cohort, 30% of unilateral cases showed germline mutation. Almost half (47%) of germline cases had inherited disease from affected (6%) parent or unaffected carrier (94%). Therefore molecular screening is critical for the genetic counseling regarding the risk for inherited RB in both unilateral and bilateral cases including those with no family history.

Indexed as

Germ-Line MutationInheritance PatternsChild, PreschoolDNA Mutational AnalysisExonsFemaleGenetic CounselingHigh-Throughput Nucleotide SequencingHumansInfantInfant, NewbornJordanMaleNeoplastic Syndromes, HereditaryProspective StudiesRetinoblastomaRB1 protein, humanRetinoblastoma Binding ProteinsUbiquitin-Protein LigasesGermlineMutationRB1 geneRetinoblastoma

Identifiers

PMID28803391
OpenAlexW2742540929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.